Cytokinetics | CYTK - Net Income

Stock Price
62.13
Daily Change
-1.39 -2.19%
Monthly
1.42%
Yearly
23.25%
Q1 Forecast
61.24

Cytokinetics reported $-306.18M in Net Income for its fiscal quarter ending in September of 2025.





Net Income Change Date
Acadia Pharmaceuticals USD 71.78M 45.11M Sep/2025
Amgen USD 1.33B 1.88B Dec/2025
Bayer EUR -963M 764M Sep/2025
Biogen USD 466.5M 168.3M Sep/2025
Bristol-Myers Squibb USD 1.09B 1.11B Dec/2025
Cytokinetics USD -306.18M 171.81M Sep/2025
Eisai JPY 10.16B 4.32B Sep/2025
Eli Lilly USD 6.64B 1.05B Dec/2025
Exelixis USD 193.58M 8.73M Sep/2025
Geron USD -18.43M 2.05M Sep/2025
Halozyme Therapeutics USD 175.22M 10.06M Sep/2025
Ionis Pharmaceuticals USD -128.61M 252.16M Sep/2025
Ligand Pharmaceuticals USD 117.27M 112.43M Sep/2025
Merck USD 2.96B 2.82B Dec/2025
Novartis USD 3.93B 96M Sep/2025
Pfizer USD -1.65B 5.19B Dec/2025
Regeneron Pharmaceuticals USD 844.6M 615.4M Dec/2025
Roche Holding CHF 5.47B 1.76B Dec/2025
Sanofi EUR -801M 3.6B Dec/2025